CTmedic quote...You are completely correct. Immunology and
CTmedic quote...You are completely correct. Immunology and it’s intersection with the “conventional” medicine of cardiology, cancer, infectious disease is still developing. The larger medical world doubts but just leronlimab, but immmune disregulation because it is poorly understood and was not part of their medical education."
CT, I say, yep, CCR5 research exploded with the Timothy Brown patient in the very early days of gene edits. Hundreds of mAb's flamed out and caused with all sorts of side effects. Massive crash and burns from the Sangamo's of the world added fuel to the fire. Research on the axis died off. The CCL5/CCR5 axis continued to get noticed as out of whack but researchers were too busy down in the weeds looking for some wildly expensive and complex gene edit for the answers.
Along comes Nader and the BOD who allowed the purchase of Pro 140 and voila, it lives, like Frankenstein resurrected in a sci-fi movie. The amount of CCL5/CCR5 axis indications in the last 2-5 years of research is off the chart. Does it mean we can control or cure all of them, no way, not possible. But we do have the top dog in CCR5 block-aid, there is no other like it anywhere in any research ever presented.
The oldest cliche in the book can't be discounted, "where there is smoke, there is fire".....
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...
Continue Reading
Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...
Continue Reading
Curaleaf's Determined Pursuit of Aurora Another day, another chess move in the cannabis world. Curaleaf is standing tall amid talk of a buyout, putting a foot forward to highlight its determination in the battle for Aurora. They've put forth an alternative to the proposal poised by Organigram, raising stakes and eyebrows alike. Aurora Cannabis is in the middle of a dance...
Continue Reading
Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...
Continue Reading
Pyramid Pharma: Breaking New Ground in Blood Cancer Treatments There's a new player making waves in the battle against rare blood cancers: Pyramid Pharma Services. This U.S.-based contract development and manufacturing organization is stepping up its game by finessing a cartridge-based product designed to treat those rare and tricky blood maladies. The canvas? A...
Continue Reading
New Crosshairs on Coastal Financial Corporation Man, it's another day and yet another fiasco in the corporate world. Late-breaking news from the trenches alerts us that Coastal Financial Corporation is in the legal spotlight. Yeah, you heard me right. We're talking about NASDAQ:CCB, the darlings turned defendants courtesy of recent allegations that could rock their stock....
Continue Reading
Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...
Continue Reading
Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...
Continue Reading
The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...
Continue Reading
Peering into the Q3 Crystal Ball When a company drops its quarterly results, it's like unveiling a new episode in an ongoing drama, and the Multiconsult ASA (Oslo: MULTI) saga is no exception. In their third quarter of 2026, the performance started to show signs of life following a somewhat sluggish run. While the numbers aren't sky-high, they're a solid indication that...
Continue Reading
Top 5 Most Recently Viewed Articles
Mobilizing for Equality: Texas AAPI Community Stands United Communities across Texas are coming together in a powerful display of solidarity against discriminatory Senate Bill 17 (SB 17) and House Bill 17 (HB 17). Both pieces of legislation propose to ban or severely restrict real estate ownership for certain foreign nationals, all while cloaked in the guise of protecting...
Continue Reading
Duke Energy Foundation's Commitment to Community Resilience Duke Energy Foundation, along with Duke Energy, has made a significant impact by investing over $33 million in nonprofit organizations. This funding supports efforts aimed at enhancing community resilience, emergency preparedness, and disaster relief activities. The partnership extends across multiple states,...
Continue Reading
eCential Robotics Welcomes New Leadership to Accelerate Growth in the U.S. eCential Robotics, an innovator in surgical robotics, is thrilled to announce the recent appointments of Lisa Jacobs as President for North America and Matthieu Ville as Vice President of Marketing. These strategic hires are designed to bolster the company's growth and innovation efforts in the...
Continue Reading
Understanding Michelin's Share Buyback Program Michelin, a leader in tire manufacturing and innovation, is continuously taking steps to enhance its shareholder value. Investors often look for tangible actions reflecting a company's commitment to their financial growth. One of the most significant methods companies utilize to support their stock price and return capital to...
Continue Reading
InterDigital's Promising New License Agreement and Q3 Outlook Smartphone Licensing Agreement Enhances Revenue Predictions Recently, InterDigital, Inc. (Nasdaq: IDCC), a prominent player in the mobile technology field, announced an exciting update that significantly alters its revenue expectations for the third quarter. The company has secured a major licensing agreement...
Continue Reading